INTRODUCTION
There is convincing evidence from multiple studies that used a variety of methodologies and were performed in different species that the mother's level of psychosocial stress during pregnancy is significantly associated with suboptimal developmental outcomes in her offspring. Evidence from controlled animal studies demonstrates that maternal stress during pregnancy can permanently compromise neurodevelopment in the offspring. 1, 2 Prenatal stress has been linked to a range of adverse outcomes in the offspring, including disturbances in attention, 3, 4 impaired learning and disruption in neurogenesis, 1, 5 and increased anxiety-like behaviors. 3 The strength of the causal claim that maternal stress affects the development of offspring is based on rigorous controlled experiments in which the prenatal effect is distinguished from postnatal effects by using methods such as cross-fostering or nursery rearing. Furthermore, there is now good evidence that at least some aspects of the underlying mechanisms have been identified. The strongest candidate is the maternal hypothalamic-pituitary-adrenal (HPA) axis, although other systems are likely to be involved. Prenatal stress causes long-term alterations in the functioning of the offspring's HPA axis, 6, 7 and each of the phenotypic outcomes identified above can be linked to disruptions in the HPA axis. A pathway by which prenatal stress impairs fetal stress architecture may be via downregulation of placental 11B-hydroxysteroid dehydrogenase type 2, which is the enzyme that metabolizes cortisol into its inactive form, cortisone. [8] [9] [10] Several nonexperimental, prospective, studies of humans have shown that maternal stress during pregnancy is associated with outcomes and psychological processes relevant to mental health including obstetric complications, 11 shorter gestational length, 12 smaller infant size at birth, 13 individual differences in the diurnal rhythm and reactivity of the offspring's HPA axis, 14, 15 and temperamental problems. 16 This pattern of findings in humans closely mirrors the findings from controlled animal studies.
Given this strong evidence for the negative impact of maternal stress during pregnancy on the offspring and the viable hypothesis that prenatal stress disrupts the programming of the systems involved in stress response, including the HPA axis, it is important to initiate studies of the prevention of the negative effects of prenatal stress in humans. This is especially relevant for sociodemographically vulnerable populations of women who are at higher risk for adverse birth outcomes 18 and whose offspring show evidence of less optimal neurodevelopmental outcomes, 19 including mental health problems. 20 For example, women living in poverty have higher rates of preterm birth, and their infants have lower birth weights. 21 African American women living in dense, urban areas with high levels of poverty appear to have the highest risk for adverse birth outcomes. 22 Adequate prenatal nutrition is a critical component of subsequent healthy growth and development, and brain development is particularly sensitive to adequate proteins and lipids. 23, 24 There are several reviews on the importance of n-3 fatty acids for offspring cognition and vision [25] [26] [27] and on the role of fatty acid status and supplementation in the etiology and treatment of physical and mental disorders across the lifespan. 27, 28 In contrast, the present review was conducted from the perspective of a prenatal programming hypothesis 29 ; the focus is, thus, on the recent findings from psychiatry, obstetrics, and animal and human research available through PubMed with particular emphasis on the role of docosahexaenoic acid (DHA) in the modulation of prenatal stress as it relates to offspring neurodevelopment. The aim was to determine whether the existing literature on the role of fatty acids in regulation of prenatal stress supports fatty acid supplementation during pregnancy among vulnerable populations as a targeted preventive intervention for common childhood mental disorders by buffering the developing fetus from the deleterious effects of maternal stress during pregnancy.
SECULAR CHANGES IN CONSUMPTION OF POLYUNSATURATED FATTY ACIDS
Polyunsaturated fatty acids (PUFAs) are comprised of two families: 1) linoleic acid and its n-6-derivative, arachadonic acid, and 2) a-linoleic acid and its n-3 derivatives, eicosapentaenoic acid and DHA. Omega-6 fatty acids are mostly found in plant oils, whereas n-3 fatty acids are found mostly in marine oils. The most important and abundant PUFA in the brain is DHA, which serves a critical role in neural functioning. 23, 24 PUFAs are not synthesized endogenously. Consequently, diet determines the level of fatty acid available to the central nervous system. Because n-6 and n-3 fatty acids compete for the same enzymes required for desaturation and elongation, a higher ratio of n-6 to n-3 PUFAs in the diet reduces the availability of DHA. Over the past several decades, dietary intake of n-3 PUFAs has decreased in the United States, whereas dietary intake of n-6 PUFAs has held relatively steady. 30, 31 In a recent review, average intake of n-3 fatty acids from seafood in the United States was <150 mg/day, which is far less than the optimal consumption of 250 mg/day. 32 Among pregnant women living in low-income environments, n-3 fatty acid intake and blood levels of DHA are approximately a quarter of the recommended levels for pregnant women. 33 Importantly, changing the level of fish consumption is not the only mechanism by which to increase n-3 PUFAs, as fish oil supplementation during pregnancy has been shown to increase DHA levels in maternal and cord plasma and erythrocyte phospholipids. 34 
DOCOSAHEXAENOIC ACID AND PERINATAL DEPRESSION
In animal models, adverse changes in central nervous system functioning in offspring have been found after administration of selective serotonin reuptake inhibitors during pregnancy. 35, 36 As a result, alternative therapies for perinatal depression, including randomized controlled trials (RCTs) of essential fatty acids, have been explored. In general, the results provide little evidence for the efficacy of fatty acid supplements in reducing depressive symptoms or preventing postpartum depression. For example, Marangell et al. 37 conducted a randomized placebocontrolled clinical trial of 2 g/day of DHA or placebo for 6 weeks; the severity of postpartum depression ratings was not different between the two groups at the end of the trial. In a few studies, trends or inconsistent results were reported regarding the association between fatty acid supplementation and perinatal depression. Results from a large RCT conducted in Australia revealed nonsignificant trends of lower depression scores among women receiving DHA during pregnancy. 38 In a recently completed trial, DHA plasma levels were inversely associated with depression scores at 34-36 weeks gestation but not at other times during pregnancy or in the postpartum period. 39 As an adjunct treatment to standard psychopharmacologic interventions for depression, however, the addition of fatty acid supplementation was associated with greater overall improvement in depression during pregnancy compared with psychopharmacologic treatment alone. 40 
DOCOSAHEXAENOIC ACID AS A MODULATOR OF STRESS HORMONES
Although PUFA supplementation does not appear to be effective in reducing clinically significant depressive symptoms in women during the perinatal period, it is possible that supplementation affects systems related to depression, such as those involved in regulating stress. This may explain the efficacy of PUFA supplementation as an adjunct treatment for depression. In animal studies, DHA supplementation was associated with a decreased stress response to controlled stimuli. For example, Takeuchi et al. 41 reported that DHA supplementation reduced stress behaviors (e.g., rearing, smelling, freezing) that were manifest in response to a corticotropin-releasing hormone infusion and to a conditioned fear response. In a study designed to test the effects of DHA supplementation on cardiac responses to psychosocial stress, stressed Wistar rats receiving DHA supplements demonstrated lower heart and blood pressure compared with stressed rats whose diets were not supplemented. 42 In humans, fatty acid supplementation was also associated with reductions in stress reactivity in controlled studies. Maes et al. 43 found an association between university students' inflammatory cytokine responses to oral exams and serum n-3 PUFA levels. Students were above the mean in their serum n-3 PUFA levels prior to the stressor, demonstrating significantly lower levels and changes in several proinflammatory cytokines including interleukin-6. Results of a 12-week RCT of n-3 supplementation in healthy men who were exposed repeatedly to a social stressor revealed that n-3 supplementation modulated the cortisol stress response, especially among individuals who reported high levels of chronic stress. 44 Yehuda et al. 45 reported on the efficacy of a daily dose of 225 mg n-3 fatty acid (taken for 1 month) for reducing test anxiety among students. Morning cortisol levels were assessed at the beginning of the study and then 1 month later among 126 participants divided into 3 groups: students without test anxiety receiving no supplement, students with test anxiety receiving placebo, and students with test anxiety receiving a supplement containing 225 mg/day of n-3 fatty acid. Morning cortisol levels decreased significantly from the pre-to the post study periods in the supplement group, and the morning cortisol levels of these individuals were similar to those of the students without test anxiety. In contrast, pre-to post-study morning cortisol levels did not change in the placebo group. Delarue et al. 46 reported a blunting of the cortisol response to stress in the context of an open trial in seven participants. All participants received 7.2 g/day of fish oil and completed a mental arithmetic challenge and the Stroop test at two time points, i.e., prior to and 3 weeks after supplementation. The magnitude of change in cortisol levels measured in response to the stressors significantly decreased from the pre-to the post-n-3 supplementation period.
Thus, there is growing evidence that supplementation with n-3 fatty acids can modify psychological responses to stressors. In the controlled experiments described above, the magnitude of the response of systems involved in the regulation of stress, including the HPA axis, was decreased by DHA supplementation.
EVIDENCE FOR AN ASSOCIATION BETWEEN DOCOSAHEXAENOIC ACID LEVELS DURING PREGNANCY AND OFFSPRING OUTCOMES
Fetal demand for DHA appears to increase during the third trimester when there is rapid development of the brain and retina. 47 Data from studies using rodent models firmly support the importance of DHA in neuronal arborization and synaptogenesis during fetal life 48 as well as myelination and synaptogenesis in the postnatal brain. 49 Tests of the association between DHA levels during pregnancy and offspring outcomes provide further evidence for the hypothesis that DHA modulates the effects of prenatal stress. These studies are summarized in Table 1 for experimental rodent models and in Table 2 for experimental and observational studies in humans. In experimental rodent models, deficient levels of DHA during pregnancy resulted in deficits in learning, such as habituation to novelty and latency to reach learning criteria 50 ; prolonged corticosterone response to restraint stress and longer periods of immobility during the Porsolt forced swim test 51 ; and less exploration of environmental stimuli in the offspring, 52 as determined via tests designed to assess constructs similar to distress disorders in humans. Takeuchi et al. 41 demonstrated that pups of DHA-deficient dams spent less time in the open arms of a plus maze (indicative of higher stress levels) than the offspring of normally fed animals. A 1-week period of DHA supplementation to the diet of the pups, however, resulted in significant increases in time spent in the open arms of the maze. In one of the most compelling experimental studies to date, Feng et al. 53 demonstrated in a rodent model that DHA administration during pregnancy attenuated the effects of prenatal stress on offspring hippocampal functioning including observed learning and memory, apoptosis, and mitochondrial metabolism. In another rodent model, the offspring of dams that were supplemented with DHA and eicosapentaenoic acid beginning in preconception and continuing through lactation showed an attenuation of the behavioral and cognitive deficits Motor activity, behavior in elevated plus maze and learning acquisition in water maze Motor activity in terms of time (P < 0.01) and distance (P < 0.005) was increased over time in the F3 generation of n-3-deficient dams; for both generations, offspring of the n-3-deficient group showed a longer escape latency (F2, P < 0.05; F3, P < 0.005) and delayed learning in the water maze (F2 P < 0.005; F3 P < 0.005) compared with the n-3-adequate group; no group differences in behavior in the plus maze Takeuchi typically elicited by olfactory bulbectomy, a manipulation that results in a phenotype consistent with depression in humans. 54 To date, studies of DHA levels in pregnant women and the impact on their offspring have been largely focused on immediate birth outcomes including birth weight, infant head circumference, and length of gestation. In a recently completed RCT of DHA supplementation during the second half of pregnancy in approximately 300 women, DHA supplementation resulted in significantly longer gestation, heavier and longer newborns, and offspring with larger head circumferences. 55 A few investigators have observed an association between DHA consumption during pregnancy and later child developmental functioning. Using a populationbased sample of close to 12,000 women, Hibbeln et al. 56 tested the association between maternal report of seafood consumption during pregnancy and offspring development. Women who reported greater psychosocial adversity, including lower education and overcrowding in the home, were less likely to consume three or more servings of fish per week. After controlling for these psychosocial factors, however, low or no fish consumption during pregnancy was significantly associated with suboptimal communication skills, verbal IQ, fine motor skills, and social communication in the child, with findings extending out to age 8 years. In another observational study, a test of the association between levels of fatty acids in cord blood and maternal report of behavioral and emotional problems in children at 10 years of age revealed significant negative associations; higher levels of fatty acids were associated with lower levels of behavior problems. 57 The results of studies evaluating offspring neurodevelopment have been mixed among the few doubleblind, randomized, controlled studies of DHA supplementation during pregnancy in humans. Helland et al. 58 assigned 341 women to receive either 10 mL/day of cod liver oil (1,183 mg DHA) or corn oil beginning at gestational week18 and continuing through postpartum month 3. All of the mothers breastfed their infants during this period. At the age of 4 years, the children's cognitive development was assessed. Children whose mothers received cod liver oil during pregnancy had IQ scores that were significantly higher than children whose mothers received corn oil during pregnancy (IQ, 106.4 versus 102.3; P < 0.05). Even after controlling for birth outcomes, cod liver oil intake during infancy, and other potential confounding variables, maternal intake of cod liver oil during pregnancy was the only significant predictor of IQ at age 4 years. These effects were not maintained at age 7 years. 59 Positive associations between DHA supplementation and offspring neurodevelopment in another RCT were observed only when the odds of scoring in the highest range as a function of DHA levels in cord blood were tested. 60 Other RCTs of DHA supplementation during pregnancy have resulted in higher heart rate variability and higher scores on the neonatal behavioral assessment scale 61 and in more protected sleep during the neonatal period. 62 In the DHA to Optimize Mother Infant Outcome Study, a large RCT of DHA supplementation in a community sample of pregnant Australian women, supplementation resulted in fewer preterm births. However, there were no effects on later cognitive functioning assessed in a subsample of children at age 18 months. 38 One possible reason for the mixed findings in humans is that DHA effects may be observed primarily in vulnerable populations with respect to maternal health or under conditions of stress with respect to offspring functioning. In the majority of experimental animal studies, effects of DHA on offspring functioning were observed under conditions of manipulated prenatal stress and/or manipulated stress exposure in the offspring as opposed to typical functioning. Even in the DHA to Optimize Mother Infant Outcome Study there was evidence of efficacy among subpopulations. Although mean cognitive scores did not differ between the two groups, toddlers in the control groups were more likely than toddlers in the DHA group to have scores in the delayed range. 38 
POTENTIAL FOR IMPROVING MENTAL HEALTH OUTCOMES IN VULNERABLE POPULATIONS VIA FATTY ACID SUPPLEMENTATION DURING PREGNANCY
The extant data support the following hypotheses: that prenatal stress confers neurodevelopmental risks in offspring; that DHA supports a more modulated response to stress; that DHA levels during pregnancy are associated with neurodevelopment in offspring; and that supplementing the diet of mothers with DHA during pregnancy can lead to more optimal outcomes in the child. Importantly, research using animal models shows that DHA administration during pregnancy attenuates the effects of prenatal stress on offspring neurodevelopment. Although the literature on both animals and humans supports the hypothesis that fatty acid supplementation may be most beneficial for pregnant women exposed to high levels of stress, to date no investigator has tested whether supplementing the diets of women who are experiencing acute and/or chronic stress will improve maternal health and reduce the suboptimal development outcomes in humans.
In the United States, higher levels of acute and chronic stress are found among families living in low-income environments than among families living in other income environments; neighborhood disorder, lack of safety, and exposure to violence are all significantly higher in areas with lower per capita income. 63, 64 African Americans live in poverty at a disproportionately high rate of more than a quarter. 65 Pregnant women living in poverty are at higher risk for poor nutrition during pregnancy 66 and are more likely to experience pregnancy complications. 18 This is especially true for African American women living in urban lowincome environments. 22 Greater exposure to psychosocial stress during the prenatal period has been hypothesized to be a primary mechanism by which poverty confers risk for physical and mental health disorders to the offspring. 67, 68 This is a viable hypothesis given the data on the impact of race and poverty on the functioning of the HPA axis and stress reactivity. Higher levels of cortisol in the afternoon and evening were found among individuals living in a low socioeconomic environment compared to individuals living in a high socioeconomic environment. 69 Within a sample of postmenopausal women caring for a disabled family member, African American women were more likely to demonstrate a significant increase in cortisol in response to a psychosocial stressor than were European American women. 70 Race differences in HPA-axis functioning and stress reactivity were also observed during pregnancy. High levels of cumulative stress were associated with elevations in corticotropin-releasing hormone, a key factor in HPA-axis regulation, among pregnant African American women but not among pregnant Hispanic women. 71 Data from studies that used exposure to a controlled stressor provide evidence for racial differences in inflammatory response (i.e., interleukin-6) to stress, with African American pregnant and nonpregnant women showing higher responses than European American pregnant and nonpregnant women. 72 In a study in which both cortisol and proinflammatory cytokines were measured during pregnancy, minority race and low-income status were characterized by high levels of cortisol without a compensatory decrease in cytokines, suggesting impaired feedback between the neuroendocrine and immune systems. 73 Thus, race and socioeconomic status appear to impact both the diurnal rhythm and feedback loop of the stress response system as well as the interface between the HPA axis and other systems critical for maintaining health, such as immune functioning. These data provide further support for the hypothesis that health disparities among racial minorities and families living in poverty may be due, in part, to differential exposure to prenatal stress. Research aimed at reducing prenatal stress among vulnerable populations could have a significant impact on the mental health of children.
CONCLUSION
In summary, several areas of research converge to support future investigations of the efficacy of prenatal fatty acid supplementation as a preventive intervention for child mental health problems. First, a primary means by which prenatal stress affects offspring development is via exposure of the fetus to high levels of glucocorticoids released by the mother. Second, experimental data in animals demonstrate that DHA supplementation can buffer such effects and protect the integrity of systems involved in cognition as well as behavior and emotion regulation. Third, RCTs of fatty acid supplementation in humans support positive effects on gestational length and provide some evidence for more optimal neurodevelopment in the offspring. This research focus on prenatal DHA supplementation in humans has not yet been applied to vulnerable populations, nor have dimensions of psychological functioning been assessed as outcome measures. Future research is needed to determine whether DHA supplementation is associated with a more modulated response to stress and more optimal behavioral and emotional regulation in the human infant, even within the context of exposure to significant prenatal stress. If such an association can be established, then a comprehensive program of research on the mechanisms by which these associations evolve can be launched, with the aim of informing the prevention of suboptimal mental health outcomes among vulnerable children.
